Literature DB >> 5774

Catecholamine enzymes in the degenerative neurological disease idiopathic orthostatic hypotension.

I B Black, C K Petito.   

Abstract

Discrete brain areas and sympathetic ganglia obtained at autopsy from patients with idiopathic orthostatic hypotension were assayed for tyrosine hydroxylase and dopamine beta-hydroxylase. Dopamine beta-hydroxylase activity was decreased 7.5-fold in sympathetic ganglia, while tyrosine hydroxylase activity was reduced more than 50-fold in the pontine nucleus locus coeruleus. These observations indicate that noradrenergic neurons of both brain and ganglion are affected in idiopathic orthostatic hypotension, but suggest that the central and peripheral biochemical deficits differ.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 5774     DOI: 10.1126/science.5774

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  5 in total

1.  Abnormal suppression of arginine-vasopressin by clonidine in multiple system atrophy.

Authors:  J Kimber; L Watson; C J Mathias
Journal:  Clin Auton Res       Date:  1999-10       Impact factor: 4.435

2.  Central adrenoceptors and cholinoceptors in cardiovascular control.

Authors:  K P Bhargava; I P Jain; A K Saxena; J N Sinha; K K Tangri
Journal:  Br J Pharmacol       Date:  1978-05       Impact factor: 8.739

Review 3.  Dysautonomia in Parkinson disease.

Authors:  David S Goldstein
Journal:  Compr Physiol       Date:  2014-04       Impact factor: 9.090

Review 4.  Different phenoconversion pathways in pure autonomic failure with versus without Lewy bodies.

Authors:  David S Goldstein; Risa Isonaka; Guillaume Lamotte; Horacio Kaufmann
Journal:  Clin Auton Res       Date:  2021-10-20       Impact factor: 4.435

5.  Differential abnormalities of cerebrospinal fluid dopaminergic versus noradrenergic indices in synucleinopathies.

Authors:  David S Goldstein; Patti Sullivan; Courtney Holmes; Guillaume Lamotte; Abhishek Lenka; Yehonatan Sharabi
Journal:  J Neurochem       Date:  2021-05-21       Impact factor: 5.546

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.